Princeton Global Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.97M Sell
5,815
-60
-1% -$61.3K 1% 26
2026
Q1
$5.4M Buy
5,875
+3,022
+106% +$3.06M 0.88% 31
2025
Q4
$3.07M Buy
2,853
+2,266
+386% +$2.17M 0.5% 54
2025
Q3
$448K Buy
587
+2
+0.3% +$1.49K 0.07% 139
2025
Q2
$456K Buy
585
+123
+27% +$95.6K 0.08% 127
2025
Q1
$382K Sell
462
-122
-21% -$102K 0.08% 140
2024
Q4
$451K Sell
584
-66
-10% -$54.6K 0.08% 135
2024
Q3
$576K Buy
650
+92
+16% +$82.7K 0.11% 120
2024
Q2
$505K Hold
558
0.11% 106
2024
Q1
$434K Sell
558
-3
-0.5% -$2.13K 0.1% 116
2023
Q4
$327K Buy
561
+4
+0.7% +$2.33K 0.08% 128
2023
Q3
$299K Hold
557
0.09% 128
2023
Q2
$261K Hold
557
0.08% 148
2023
Q1
$191K Buy
557
+50
+10% +$16.9K 0.06% 167
2022
Q4
$185K Hold
507
0.06% 153
2022
Q3
$164K Hold
507
0.06% 158
2022
Q2
$164K Sell
507
-35
-6% -$10.5K 0.05% 166
2022
Q1
$155K Sell
542
-83
-13% -$21.4K 0.04% 181
2021
Q4
$173K Hold
625
0.05% 180
2021
Q3
$144K Hold
625
0.04% 188
2021
Q2
$143K Hold
625
0.04% 187
2021
Q1
$117K Buy
625
+83
+15% +$16.2K 0.04% 190
2020
Q4
$92K Hold
542
0.03% 201
2020
Q3
$80K Sell
542
-933
-63% -$144K 0.03% 191
2020
Q2
$242K Buy
1,475
+300
+26% +$46K 0.08% 170
2020
Q1
$163K Buy
1,175
+77
+7% +$10.6K 0.07% 165
2019
Q4
$144 Buy
1,098
+633
+136% +$73.4K 0.06% 169
2019
Q3
$52K Sell
465
-180
-28% -$20K 0.03% 206
2019
Q2
$71K Hold
645
0.04% 190
2019
Q1
$83K Hold
645
0.06% 164
2018
Q4
$75K Buy
+645
New +$72.1K 0.07% 146

Other funds holding LLY

Princeton Global Asset Management's LLY Position: Q2 2026 in Review

Princeton Global Asset Management reduced its Eli Lilly (LLY) stake by 1% in Q2 2026, selling an estimated $61.3K and leaving 5,815 shares worth $6.97M. The position accounts for 1% of the portfolio, ranked #26.

Princeton Global Asset Management first reported a position in LLY in Q4 2018 and has held it in 31 quarters since. 1,691 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Princeton Global Asset Management held 5,815 shares of Eli Lilly worth $6.97M as of Q2 2026.
  • Princeton Global Asset Management sold 60 Eli Lilly shares in Q2 2026, an estimated $61.3K.
  • Eli Lilly made up 1% of Princeton Global Asset Management's portfolio in Q2 2026, its #26 holding.
  • Princeton Global Asset Management first reported a position in Eli Lilly in Q4 2018 and has held it in 31 quarters since.
  • 1,691 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Princeton Global Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.